The short-term outlook is bullish for Glenmark Pharmaceuticals. The 5 per cent rise on Tuesday confirms an inverted head and shoulder pattern on the chart.

This indicates that the broader uptrend has resumed. The neckline support of this pattern is around ₹2,140. Moving average cross overs on the daily chart also strengthens the bullish case. So, any dips from here can be limited.

Glenmark Pharmaceuticals share price can rise to ₹2,450 initially and then ₹2,600 eventually in the coming weeks.

Video Credit: Businessline

Traders can buy Glenmark Pharmaceuticals shares now at ₹2,228. Accumulate on dips at ₹2,180. Keep the stop-loss at ₹2,110 initially.

Trail the stop-loss up to ₹2,250 as soon as the stock goes up to ₹2,290. Revise the stop-loss higher to ₹2,310 and ₹2,360 when the price touches ₹2,345 and ₹2,395 respectively. Exit the longs at ₹2,420.

(Note: The recommendations are based on technical analysis. There is risk of loss in trading.)

Published on March 11, 2026